Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

CUSIP: 29384C108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
38,346,880
Total 13F shares
26,027,444
Share change
-254,417
Total reported value
$368,797,900
Price per share
$14.17
Number of holders
76
Value change
-$3,772,264
Number of buys
36
Number of sells
26

Security key

29384C108

Report period

Q1 2024

Institutions

76

Top holders

10

Top shareholders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
13%
4,865,819
$73,425,209 31 Dec 2023
13F
MPM ASSET MANAGEMENT LLC
13F
Company
12%
4,425,784
$66,785,081 31 Dec 2023
13F
5AM Venture Management, LLC
13F
Company
11%
4,408,379
$66,522,439 31 Dec 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
7.8%
3,009,673
$45,416,000 31 Dec 2023
13F
BlackRock Finance, Inc.
13F
Company
3.9%
1,502,537
$22,673,285 31 Dec 2023
13F
Redmile Group, LLC
3/4/5 13F
10%+ Owner · Company
3.3%
from 13F
1,954,420
$31,251,176 02 Nov 2021
VANGUARD GROUP INC
13F
Company
2.8%
1,065,166
$16,073,355 31 Dec 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.7%
1,047,780
$15,811,001 31 Dec 2023
13F
StepStone Group LP
13F
Company
2%
761,277
$11,487,670 31 Dec 2023
13F
TCG Crossover Management, LLC
13F
Company
1.5%
584,955
$8,826,971 31 Dec 2023
13F
FMR LLC
13F
Company
1.4%
535,523
$8,081,042 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
459,381
$6,932,745 31 Dec 2023
13F
STATE STREET CORP
13F
Company
1.1%
427,832
$6,455,985 31 Dec 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.62%
238,645
$3,601,153 31 Dec 2023
13F
NORTHERN TRUST CORP
13F
Company
0.52%
200,688
$3,028,381 31 Dec 2023
13F
72 Investment Holdings, LLC
13F
Company
0.45%
172,600
$2,604,534 31 Dec 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.39%
151,358
$2,283,992 31 Dec 2023
13F
TD ASSET MANAGEMENT INC
13F
Company
0.31%
119,254
$1,799,543 31 Dec 2023
13F
Bank of New York Mellon Corp
13F
Company
0.3%
115,060
$1,736,256 31 Dec 2023
13F
Advantage Alpha Capital Partners LP
13F
Company
0.27%
105,137
$1,586,517 31 Dec 2023
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
0.27%
105,000
$1,584,450 31 Dec 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.21%
80,510
$1,214,896 31 Dec 2023
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.15%
55,675
$840,136 31 Dec 2023
13F
MORGAN STANLEY
13F
Company
0.13%
49,304
$743,997 31 Dec 2023
13F
Nan Fung Group Holdings Ltd
13F
Company
0.13%
49,082
$740,647 31 Dec 2023
13F
BARCLAYS PLC
13F
Company
0.08%
31,730
$478,805 31 Dec 2023
13F
NATIXIS
13F
Company
0.08%
31,186
$517,376 31 Dec 2023
13F
Corton Capital Inc.
13F
Company
0.07%
28,576
$431,212 31 Dec 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
28,492
$429,934 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.07%
27,430
$413,919 31 Dec 2023
13F
STRS OHIO
13F
Company
0.06%
24,100
$363,000 31 Dec 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.06%
23,967
$361,662 31 Dec 2023
13F
Swiss National Bank
13F
Company
0.06%
23,000
$347,070 31 Dec 2023
13F
UBS Group AG
13F
Company
0.06%
22,476
$339,163 31 Dec 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
18,064
$272,589 31 Dec 2023
13F
Invesco Ltd.
13F
Company
0.05%
17,296
$260,997 31 Dec 2023
13F
CREDIT SUISSE AG/
13F
Company
0.04%
15,856
$239,267 31 Dec 2023
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
14,210
$214,429 31 Dec 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
14,154
$213,584 31 Dec 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.03%
13,206
$199,279 31 Dec 2023
13F
Oracle Alpha Inc.
13F
Company
0.03%
12,500
$188,625 31 Dec 2023
13F
SG Americas Securities, LLC
13F
Company
0.03%
11,714
$177,000 31 Dec 2023
13F
MetLife Investment Management, LLC
13F
Company
0.03%
11,694
$176,462 31 Dec 2023
13F
Legal & General Group Plc
13F
Company
0.03%
11,062
$167,410 31 Dec 2023
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.03%
10,874
$164,089 31 Dec 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
10,636
$160,497 31 Dec 2023
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
9,808
$148,003 31 Dec 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
8,877
$133,954 31 Dec 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
7,085
$107,000 31 Dec 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
6,627
$100,002 31 Dec 2023
13F

Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q1 2024

As of 31 Mar 2024, Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,027,444 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, StepStone Group LP, and TCG Crossover Management, LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
62
Q1 2024 holders
76
Holder diff
14
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .